Variant position: 287 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 840 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RIPTEHLLRGSPP-PPQRRYG HTMVAFDRHLYVFGGAADNTL
Mouse RIPTEHLLRGSPP-PPQRRYG HTMVAFDRHLYVFGGAADNT
Drosophila RISNEPVLRGATSAPPSRRYG HTMVHHDRFLYVFGGSADST
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 840 Leucine-zipper-like transcriptional regulator 1
Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
Yamamoto G.L.; Aguena M.; Gos M.; Hung C.; Pilch J.; Fahiminiya S.; Abramowicz A.; Cristian I.; Buscarilli M.; Naslavsky M.S.; Malaquias A.C.; Zatz M.; Bodamer O.; Majewski J.; Jorge A.A.; Pereira A.C.; Kim C.A.; Passos-Bueno M.R.; Bertola D.R.;
J. Med. Genet. 52:413-421(2015)
Cited for: INVOLVEMENT IN NS10; VARIANTS NS10 CYS-119; ASN-247; ARG-248; CYS-284 AND TYR-287; VARIANTS LEU-447 AND VAL-647;
LZTR1 is a regulator of RAS ubiquitination and signaling.
Bigenzahn J.W.; Collu G.M.; Kartnig F.; Pieraks M.; Vladimer G.I.; Heinz L.X.; Sedlyarov V.; Schischlik F.; Fauster A.; Rebsamen M.; Parapatics K.; Blomen V.A.; Mueller A.C.; Winter G.E.; Kralovics R.; Brummelkamp T.R.; Mlodzik M.; Superti-Furga G.;
Cited for: FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH CUL3; VARIANTS GLM ARG-105; GLY-198; ARG-248; ILE-288 AND TRP-810; CHARACTERIZATION OF VARIANTS GLM ARG-105; GLY-198; ARG-248; ILE-288 AND TRP-810; CHARACTERIZATION OF VARIANTS NS10 CYS-119; ASN-247; ARG-248 AND TYR-287; CHARACTERIZATION OF VARIANTS SWNTS2 LEU-122; ARG-404; GLY-456; GLN-466; LEU-520; CYS-688 AND ILE-813;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.